StockData
Pulmatrix, Inc. logo

Pulmatrix, Inc. (PULM) stock

PULMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$1.37+0.04 (+3.01%)

Close on Nov 17, 2026Market cap $5.00MP/E –Yield –

Pulmatrix price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Pulmatrix's price to sales ratio was 3.1× on Apr 30, 2025, against 1.0× a year earlier. Over the last 5 years it ranged from 0.6× to 5.6×, with a median of 2.9×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Apr 30, 20253.1×+0.5
2024Dec 31, 20242.5×+1.5
2023Dec 29, 20231.0×−1.9
2022Dec 30, 20222.9×−0.7
2021Dec 31, 20213.7×+0.3
2020Dec 31, 20203.3×−29.8
2019Apr 30, 201933.1×−40.5
2018Dec 31, 201873.6×+24.6
2017Apr 28, 201749.1×+40.3
2016Dec 30, 20168.8×−166.5
2015Dec 31, 2015175.3×–

More Pulmatrix figures

See a number that looks wrong?